Voloridge Investment Management, LLC Dr Reddys Laboratories LTD Transaction History

Voloridge Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $748,990 - $880,517	-12,100 Reduced 20.46%	47,053 $3.15 Million
Q2 2023 Aug 14, 2023	SELL	$53.34 - $63.11 $1.27 Million - $1.5 Million	-23,833 Reduced 28.72%	59,153 $3.73 Million
Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $58,135 - $64,103	-1,126 Reduced 1.34%	82,986 $4.72 Million
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $3.13 Million - $3.52 Million	61,210 Added 267.27%	84,112 $4.35 Million
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $534,079 - $613,495	10,703 Added 87.74%	22,902 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $605,314 - $709,127	12,199 New	12,199 $676,000
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $1.37 Million - $1.55 Million	-21,803 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $1.23 Million - $1.74 Million	-23,996 Reduced 52.39%	21,803 $1.52 Million
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $1.81 Million - $2.5 Million	45,799 New	45,799 $2.43 Million

252

34.4M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.24B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.